3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
2
Uveal Melanoma
1
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Pancreatic Neoplasms
1
Neurofibromatosis 2
1
Neoplasms, Mesothelial
1
Neoplasms
1
Mouth Neoplasms
1
Lymphangioleiomyomatosis
1
Erdheim-Chester Disease
1
Endocrine Gland Neoplasms
1
Disease Progression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Castleman Disease
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
13
Temozolomide
10
Magnetic Resonance Spectroscopy
10
dinutuximab
8
X-Rays
8
Specimen Handling
8
Irinotecan
8
Biopsy
8
Phantoms, Imaging
7
Topotecan
6
Nuclear Medicine Department, Hospital
6
fludarabine
5
Vincristine
5
3-Iodobenzylguanidine
5
fludarabine phosphate
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Etoposide
4
tipifarnib
3
sargramostim
3
Radiotherapy
3
Melphalan
3
Isotretinoin
3
Filgrastim
3
Doxorubicin
3
Carboplatin
3
ulixertinib
2
tazemetostat
2
selpercatinib
2
saponin QA-21V1
2
pembrolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Valproic Acid
×
90 days
×
Clear all
No trials found.